Drug Discovery News and Research

RSS

The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund.

6 Nov 2026

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the journal Immunity & Inflammation on October 27, 2026. The article systematically examines the translational bottlenecks and potential solutions for plant-derived anti-inflammatory compounds.

5 Nov 2026

New covalent inhibitor targets DNAJC9 to reduce sepsis inflammation

This new article publication from Acta Pharmaceutica Sinica B discusses the discovery of the covalent inhibitor A12 and the identification of DNAJC9 as a potential drug target for sepsis-associated inflammation.

5 Nov 2026

Comprehensive genetic map offers new hope for tuberculosis treatments

Rockefeller scientists have created the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB).

4 Nov 2026

DHA improves autism-like behaviors in a preclinical rat study

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition marked by social and communication difficulties and repetitive behaviors.

3 Nov 2026

New hormone receptor strategy offers targeted treatment for lupus

Researchers at the University of California, Riverside and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues.

2 Nov 2026

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Dr. Laura Ajram leads the British Neuroscience Association, focusing on enhancing neuroscience research through strategic partnerships and patient engagement.

2 Nov 2026

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: "THE COMMODITIZATION TRAP: WHO WINS WHEN EVERYONE HAS THE SAME AI?"

30 Oct 2026

Landmark studies map how genetic differences drive human diseases

In three landmark studies published in Nature today, Australian researchers have made major advances in our understanding of how genetic differences between people influence disease.

28 Oct 2026

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Discover how omics is transforming life sciences with expert insights from Dr. Shi-Qi An on multiomics, single-cell research and drug discovery.

23 Oct 2026

$8.2 million grant advances on-demand male contraceptive development

Weill Cornell Medicine has received a four-year, $8.2 million grant from the National Institute of Child Health and Human Development (NICHD) to develop and test an experimental on-demand male contraceptive pill that temporarily stops sperm in their tracks

22 Oct 2026

Cell Painting method reveals drug differences in 3D cancer cells

Researchers at Uppsala University have adapted Cell Painting, a widely used imaging method in drug discovery, to look at individual cells inside small 3D clusters of cancer cells.

21 Oct 2026

Study links abnormal immature astroglia to lower fluid intelligence in older epilepsy patients

A new USC-led study links abnormal immature astroglia, star-shaped cells that support brain function, to lower fluid intelligence, or the ability to solve new problems, in older adults with epilepsy.

20 Oct 2026

Researchers use AI to identify early-stage inhibitors for antiviral therapy

Viral infections can be difficult to treat as viruses evolve rapidly, allowing them to develop resistance to drugs designed to attack viral proteins directly.

19 Oct 2026

New paper urges adoption of green AI in healthcare

AI is already widely used in hospitals and medical research. Can a new way of thinking unleash the technology’s green credentials?

15 Oct 2026

Leading life science organizations collaborate for second London Bio-Innovation Week

One Nucleus, The Society for Laboratory Automation and Screening (SLAS), and ELRIG today announced that they will be collaborating during the second London Bio-Innovation Week, to facilitate multi-event and community networking and partnering opportunities for life science companies, academic researchers, bio-entrepreneurs, investors and advisers.

From Society for Laboratory Automation and Screening (SLAS) 15 Oct 2026

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

14 Oct 2026

Yokogawa brings publication-backed validation from more than 60,000 scientific publications to its CSU spinning disk confocal systems with Bioz

Through Bioz Badges, Yokogawa transforms its extensive publication history into a valuable resource for researchers evaluating advanced microscopy technologies.

From Yokogawa Life Science 13 Oct 2026

Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

We are pleased to announce the appointment of Dr Adrijana Vinter as Chief Executive Officer. Dr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract research industry sectors.

From Concept Life Sciences 13 Oct 2026

Experts launch Europe-wide framework to guide AI use in mental health

The first Europe-wide expert working group on Artificial Intelligence in mental health launches today to the ECNP congress in Munich, where the group will host an open discussion, setting out the potential, the problems, and possible directions for AI in psychiatry and neuroscience.

12 Oct 2026

Drug Discovery News and Research

Further Reading

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

New covalent inhibitor targets DNAJC9 to reduce sepsis inflammation

Comprehensive genetic map offers new hope for tuberculosis treatments

DHA improves autism-like behaviors in a preclinical rat study

New hormone receptor strategy offers targeted treatment for lupus

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Landmark studies map how genetic differences drive human diseases

How Omics Technologies Are Transforming Biological Research and Drug Discovery

$8.2 million grant advances on-demand male contraceptive development

Cell Painting method reveals drug differences in 3D cancer cells

Study links abnormal immature astroglia to lower fluid intelligence in older epilepsy patients

Researchers use AI to identify early-stage inhibitors for antiviral therapy

New paper urges adoption of green AI in healthcare

Leading life science organizations collaborate for second London Bio-Innovation Week

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

Yokogawa brings publication-backed validation from more than 60,000 scientific publications to its CSU spinning disk confocal systems with Bioz

Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

Experts launch Europe-wide framework to guide AI use in mental health

eBook: Image-guided automated cell culture for 2D, iPSC, and organoid workflows eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery